SEC Form D · filed December 1, 2022
Equilibre BioPharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Philip A. Barach · New York, NYExec · DirectorChristopher M. Thorn · New York, NYDirectorChristina A. Ramirez · New York, NYDirectorFrancois A. Maisonrouge · New York, NYDirectorPeter M. Simon · New York, NYDirectorDavid A. Friedman · New York, NYDirectorSteven N. Gordon · New York, NYExec · DirectorPascal E. Christory · Puteaux, I0DirectorStefan J. Corthouts · Canach, LuxembourgExec · DirectorPaul P. Bashir · London, United KingdomDirectorLisa Y. Gokongwei · Grand Cayman, Cayman IslandsDirectorDavid Hardie · Reno, NVDirectorPeyman J. Azari · Luxembourg City, LuxembourgExec · DirectorJoost J. Knabben · Luxembourg City, LuxembourgDirectorDaniel Schulte · Overland Park, KSDirectorJames Maffuccio · Overland Park, KSDirectorBen Fraser · Overland Park, KSDirectorKimberly Melen · Grand Cayman, Cayman IslandsExec · DirectorLouise Groom · Grand Cayman, Cayman IslandsExec · DirectorJustin Smithline · Chadds Ford, PADirectorAndrew T. Gi · Dallas, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗